149 related articles for article (PubMed ID: 37973190)
1. Worldwide Regulatory Reliance: Launching A Pilot on A Chemistry, Manufacturing and Control Post Approval Change for A Vaccine.
Gastineau T; Ban C; Basso A; Brehme F; Silva AL; Faure O; Le Palaire L; Persaud P; Rodriguez H
PDA J Pharm Sci Technol; 2023 Nov; ():. PubMed ID: 37973190
[TBL] [Abstract][Full Text] [Related]
2. Alignment in post-approval changes (PAC) guidelines in emerging countries may increase timely access to vaccines: An illustrative assessment by manufacturers.
Dellepiane N; Pagliusi S; Akut P; Comellas S; De Clercq N; Ghadge S; Gastineau T; McGoldrick M; Nurnaeni I; Scheppler L;
Vaccine X; 2020 Dec; 6():100075. PubMed ID: 32995745
[TBL] [Abstract][Full Text] [Related]
3. Path Forward to Optimise Post-approval Change Management and Facilitate Continuous Supply of Medicines and Vaccines of High Quality Worldwide : Joint Position from EFPIA, IFPMA and Vaccines Europe.
Deavin A; Adam S; Ausborn S; Nielsen ASB; Cappellini S; Colmagne-Poulard I; Gastineau T; Gonzalez-Martinez A; Meillerais S; Mortazavi C
Ther Innov Regul Sci; 2023 Jan; 57(1):7-11. PubMed ID: 35917091
[TBL] [Abstract][Full Text] [Related]
4. Approaches to Design an Efficient, Predictable Global Post-approval Change Management System that Facilitates Continual Improvement and Drug Product Availability.
Vinther A; Ramnarine E; Gastineau T; O'Brien L; Brehm O; Fryrear D
Ther Innov Regul Sci; 2024 May; 58(3):433-442. PubMed ID: 38369639
[TBL] [Abstract][Full Text] [Related]
5. How to accelerate the supply of vaccines to all populations worldwide? Part I: Initial industry lessons learned and practical overarching proposals leveraging the COVID-19 situation.
McGoldrick M; Gastineau T; Wilkinson D; Campa C; Clercq N; Mallia-Milanes A; Germay O; Krishnan J; Van Ooij M; Thien MP; Mlynarczyk PJ; Saltus E; Juvin P; Clenet D; Basso A; Dellepiane N; Pagliusi S; de Moraes Stávale MC; Sivaramakrishnan VH; Desai S
Vaccine; 2022 Feb; 40(9):1215-1222. PubMed ID: 35180993
[TBL] [Abstract][Full Text] [Related]
6. Reliance: a smarter way of regulating medical products - The IPRP survey.
Doerr P; Valentin M; Nakashima N; Orphanos N; Santos G; Balkamos G; Saint-Raymond A
Expert Rev Clin Pharmacol; 2021 Feb; 14(2):173-177. PubMed ID: 33355025
[No Abstract] [Full Text] [Related]
7. Evaluation of the impact of reliance on the regulatory performance in the South African Health Products Regulatory Authority: implications for African regulatory authorities.
Danks L; Semete-Makokotlela B; Otwombe K; Parag Y; Walker S; Salek S
Front Med (Lausanne); 2023; 10():1265058. PubMed ID: 37937144
[TBL] [Abstract][Full Text] [Related]
8. Chemistry Manufacturing and Controls Development, Industry Reflections on Manufacture, and Supply of Pandemic Therapies and Vaccines.
Popkin ME; Goese M; Wilkinson D; Finnie S; Flanagan T; Campa C; Clinch A; Teasdale A; Lennard A; Cook G; Mohan G; Osborne MD
AAPS J; 2022 Sep; 24(6):101. PubMed ID: 36168002
[TBL] [Abstract][Full Text] [Related]
9. WHO collaborative registration procedure using stringent regulatory authorities' medicine evaluation: reliance in action?
Vaz A; Roldão Santos M; Gwaza L; Mezquita González E; Pajewska Lewandowska M; Azatyan S; Saint-Raymond A
Expert Rev Clin Pharmacol; 2022 Jan; 15(1):11-17. PubMed ID: 35130803
[TBL] [Abstract][Full Text] [Related]
10. Medicinal Product Development and Regulatory Agilities Implemented During the Early Phases of the COVID-19 Pandemic: Experiences and Implications for the Future-An Industry View.
Geraci G; Bernat J; Rodier C; Acha V; Acquah J; Beakes-Read G
Ther Innov Regul Sci; 2023 Sep; 57(5):940-951. PubMed ID: 37266868
[TBL] [Abstract][Full Text] [Related]
11. Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization.
Ahonkhai V; Martins SF; Portet A; Lumpkin M; Hartman D
PLoS One; 2016; 11(11):e0166515. PubMed ID: 27851831
[TBL] [Abstract][Full Text] [Related]
12. A Proposal of a Combined Convergence Regulatory Strategy Applied to Post-approval Changes by Latin American Countries, Reducing Workload and Allowing Continuous Improvement to Guarantee the Quality, Safety, and Efficacy of Medicines.
Rodriguez H; De Lucia ML
Front Med (Lausanne); 2021; 8():768376. PubMed ID: 34888329
[TBL] [Abstract][Full Text] [Related]
13. Industry One-Voice-of-Quality Solutions Management Review of Post-Approval Changes Guide.
Vinther A; Mohammed F; Ramnarine E
PDA J Pharm Sci Technol; 2021; 75(5):454-457. PubMed ID: 33723006
[TBL] [Abstract][Full Text] [Related]
14. Considerations for the chemistry, manufacturing and Controls (CMC) - quality package for COVID-19 vaccines- interim lessons learnt by the European medicines Agency (EMA).
Shivji R; Conocchia R; Korakianiti E; Jekerle V
Vaccine; 2022 Sep; 40(38):5539-5541. PubMed ID: 35779964
[TBL] [Abstract][Full Text] [Related]
15. Regulatory reliance pathways during health emergencies: enabling timely authorizations for COVID-19 vaccines in Latin America.
van der Zee IT; Vreman RA; Liberti L; Garza MA
Rev Panam Salud Publica; 2022; 46():e115. PubMed ID: 36060200
[TBL] [Abstract][Full Text] [Related]
16. Regulatory Harmonization and Streamlining of Clinical Trial Applications globally should lead to faster clinical development and earlier access to life-saving vaccines.
Scheppler L; De Clercq N; McGoldrick M; Dias J
Vaccine; 2021 Jan; 39(5):790-796. PubMed ID: 33422378
[TBL] [Abstract][Full Text] [Related]
17. Harmonization of individual case safety reports transmission requirements among PAHO reference authorities: a review of their current regulation.
Lomeli-Silva A; Contreras-Salinas H; Barajas-Virgen MY; Romero-Lopez MS; Rodríguez-Herrera LY
Ther Adv Drug Saf; 2024; 15():20420986241228119. PubMed ID: 38323190
[TBL] [Abstract][Full Text] [Related]
18. Regulatory Pathways That Facilitated Timely Registration of a New Group A Meningococcal Conjugate Vaccine for Africa's Meningitis Belt Countries.
Dellepiane N; Akanmori BD; Gairola S; Jadhav SS; Parker C; Rodriguez C; Srivastava S
Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S428-33. PubMed ID: 26553671
[TBL] [Abstract][Full Text] [Related]
19. Regulatory reliance to approve new medicinal products in Latin American and Caribbean countries.
Durán CE; Cañás M; Urtasun MA; Elseviers M; Andia T; Vander Stichele R; Christiaens T
Rev Panam Salud Publica; 2021; 45():e10. PubMed ID: 33859678
[TBL] [Abstract][Full Text] [Related]
20. How to accelerate the supply of vaccines to all populations worldwide? Part II: Initial industry lessons learned and detailed technical reflections leveraging the COVID-19 situation.
McGoldrick M; Gastineau T; Wilkinson D; Campa C; De Clercq N; Mallia-Milanes A; Germay O; Krishnan J; Van Ooij M; Thien MP; Mlynarczyk PJ; Saltus E; Wauters F; Juvin P; Clenet D; Basso A; Dellepiane N; Pagliusi S; Collaço de Moraes Stávale M; Sivaramakrishnan VH; Desai S
Vaccine; 2022 Feb; 40(9):1223-1230. PubMed ID: 35180994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
